Do Stem Cell Therapies Stand a Chance Against the FDA?
There is currently a debate underway about the FDA’s authority to regulate stem cell therapies. The FDA is suing a Colorado-based company, Regenerative Sciences, which has developed a procedure to...
View ArticleThe FDA Is the Problem, Not Its Budget
The Wall Street Journal recently ran an op-ed by a former commissioner of the FDA on the agency’s impact on medical innovations such as stem cell therapy (a subject we’ve blogged about at length). The...
View Article
More Pages to Explore .....